Mangalam Organics Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mangalam Organics has filed its Q3 FY26 (quarter ended Dec 31, 2025) unaudited results along with a clean limited review report from auditor NGST & Associates. On a standalone basis, quarterly revenue from operations rose to Rs. 12,244.57 lakhs from Rs. 10,052.78 lakhs a year ago, but profit before tax fell to Rs. 149.82 lakhs (vs Rs. 378.80 lakhs in Q3 FY25) and total comprehensive income dropped to Rs. 110.65 lakhs (vs Rs. 283.25 lakhs), with EPS at Rs. 1.29 vs Rs. 3.31. On a consolidated basis, Q3 revenue was Rs. 16,429.84 lakhs (vs Rs. 12,391.66 lakhs) and profit before tax was Rs. 548.18 lakhs (vs Rs. 483.31 lakhs). For the nine-month period, consolidated revenue grew ~23% to Rs. 46,895.36 lakhs and profit before tax jumped to Rs. 2,434.67 lakhs from Rs. 1,002.66 lakhs, with 9M consolidated EPS at Rs. 23.08 vs Rs. 8.68. An exceptional item of Rs. (350.60) lakhs was booked in Q2 FY26 but is nil in Q3 FY26.
The nine-month picture is strong with double-digit revenue growth and sharply higher profits on a consolidated basis, but the sharp sequential and YoY dip in standalone Q3 profit is a red flag that may cap near-term upside. Investors should watch the standalone margin compression and whether the Q2 exceptional charge or higher finance/depreciation costs continue to weigh on quarterly earnings.